Average Co-Inventor Count = 5.07
ph-index = 7
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Allergan, Inc. (25 from 2,285 patents)
2. Other (1 from 832,843 patents)
26 patents:
1. 11332518 - Immuno-based botulinum toxin serotype A activity assays
2. 11261240 - Immuno-based botulinum toxin serotype A activity assays
3. 10912823 - Botulinum neurotoxin for treatment of disorders associated with melanocyte hyperactivity and/or excess melanin
4. 10900967 - Immuno-based retargeted endopeptidase activity assays
5. 10703806 - Immuno-based botulinum toxin serotype A activity assays
6. 10451621 - Highly sensitive cell-based assay to detect the presence of active botulinum neurotoxin serotype-A
7. 10345306 - Immuno-based retargeted endopeptidase activity assays
8. 9651553 - Immuno-based retargeted endopeptidase activity assays
9. 9625447 - Cells useful for immuno-based botulinum toxin serotype A activity assays
10. 9249216 - Immuno-based botulinum toxin serotype A activity assays
11. 8691566 - Cells useful for immuno-based botulinum toxin serotype a activity assays
12. 8663982 - Cells useful for immuno-based botulinum toxin serotype A activity assays
13. 8663983 - Cells useful for immuno-based botulinum toxin serotype A activity assays
14. 8618261 - Immuno-based botulinum toxin serotype A activity assays
15. 8603812 - Cells useful for immuno-based botulinum toxin serotype A activity assays